Stockreport

Eyepoint Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]

EyePoint, Inc.  (EYPT) 
Last eyepoint, inc. earnings: 3/5 07:00 am Check Earnings Report
PDF expects top-line Phase 3 wet AMD data beginning in mid-2026, positioning DURAVYU as a potential six-month intravitreal treatment with a multi-MOA (VEGF/PDGF/IL-6 via JAK [Read more]